Tag Archives: nanomedicine

A combined rapid microfluidics and design-of-experiment approach to optimize liposomal formulations

AoS. A combined rapid microfluidics and design-of-experiment approach

Nanomedicine has attracted enormous attention for the introduction of advantageous nanoscale materials. Among them, liposomes have devoted considerable concern owing to unique physicochemical and biological properties, as well as the tremendous potential for drug delivery applications. Over

Therapy of osteoporosis by the transdermal formulation based on raloxifene nanoparticles in ovariectomized rat

Osteoporosis results from insufficient post-menopausal estrogen levels and collapse of the balance between osteoclasts and osteoblasts, and the osteoporosis is a common systemic skeletal condition that is related to low bone mineral density and pathological fractures. The

A new strategy to deliver anti-cancer nanodrugs and decrease their toxic side effects by temporarily blunting the RES uptake using Intralipid®

Nanodrugs, or nanotechnology-based therapeutics, show great promise for treating a number of diseases, including cancer. However, an analysis of the literature from the past 10 years finds that in studies of cancer nanodrugs, a very small fraction

Getting health allies from agriculture enemies

In recent years, research in nanotechnologies has demonstrated that nanometer-sized particles constructed using a wide array of materials (e.g. metals, lipids, polymers, proteins) can offer answers to unmet questions concerning drug/vaccine delivery. Ideally, these systems should prevent

Erasing atherosclerosis with nanoparticles and near-infrared laser

The advent of nanomedicine and near-infrared (NIR) optics allows the development and design of tools that enhance diagnosis and treatment of atherosclerosis. Clinical application of these technologies is anticipated in the near future. Our trial called NANOM-FIM

A possible new treatment for Alzheimer’s disease and stroke using nanoparticles

Alzheimer’s disease (AD) and stroke are two neurological disorders that share the common feature of neuronal death. The peptide under investigation here is IRL-1620, which has been shown in previous studies to reverse neuronal death as well